CLDN1 and colorectal cancer: Cherradi et al. found that CLDN1 expression was upregulated in oxaliplatin-resistant colorectal cancer, and CLDN1 knockdown promoted the sensitivity of colorectal cancer cells to oxaliplatin [48].